Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

All for CD91 and CD91 for all.

Justin Stebbing1, Philip Savage, Steve Patterson

  • 1Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, The Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK. j.stebbing@imperial.ac.uk

The Journal of Antimicrobial Chemotherapy
|December 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet Crosstalk.

Circulation research·2020
Same author

Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.

PloS one·2019
Same author

Pharmacological impact of antiretroviral therapy on platelet function to investigate human immunodeficiency virus-associated cardiovascular risk.

British journal of pharmacology·2019
Same author

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy.

AIDS (London, England)·2018
Same author

Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.

Journal of the American Heart Association·2017
Same author

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.

The Journal of infectious diseases·2017
Same journal

Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing.

The Journal of antimicrobial chemotherapy·2026
Same journal

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same journal

Incidence and factors associated with subtherapeutic cefazolin levels among patients with severe infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Emerging resistance in staphylococci following long-term dalbavancin treatment for prosthetic joint infections.

The Journal of antimicrobial chemotherapy·2026
Same journal

Microbiology testing around the time of antibiotic initiation among residents of long-term care facilities.

The Journal of antimicrobial chemotherapy·2026
Same journal

Insights into the mechanisms underlying cell wall-active agents and gentamicin bactericidal synergism against Enterococcus faecalis.

The Journal of antimicrobial chemotherapy·2026
See all related articles

Heat shock proteins engage antigen-presenting cells via CD91, initiating immune responses. Their presence in tumors and viruses suggests potential for novel anti-cancer and anti-viral therapies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Heat shock proteins (HSPs) are crucial molecular chaperones.
  • HSPs interact with CD91 receptors on antigen-presenting cells (APCs).

Purpose of the Study:

  • To elucidate the mechanism by which HSPs interact with APCs.
  • To explore the potential of HSPs in immunotherapy.

Main Methods:

  • Investigated HSP-APC interactions via CD91.
  • Analyzed downstream signaling pathways.
  • Assessed T cell activation and peptide presentation.

Main Results:

  • HSP-CD91 interaction triggers APC maturation and activation.
  • Chaperoned foreign peptides are presented on MHC class I molecules.

Related Experiment Videos

  • This facilitates cytotoxic T cell responses.

    • Conclusions:

    • HSPs are key mediators of immune recognition.
    • HSPs in tumors and virions offer therapeutic potential for cancer and viral infections.